Literature DB >> 7942679

The natural history of abdominal pain associated with primary biliary cirrhosis.

J M Laurin1, C K DeSotel, R A Jorgensen, E R Dickson, K D Lindor.   

Abstract

OBJECTIVES: The aim of the present study was to determine the prevalence and natural history of abdominal pain in patients with primary biliary cirrhosis.
METHODS: We studied 178 patients with well-defined primary biliary cirrhosis enrolled in a prospective randomized trial of ursodeoxycholic acid. These patients underwent upper endoscopy and upper abdominal ultrasound prior to entry, at 2 yr, and as indicated. Fourteen patients had additional evaluations including abdominal CT (four), colon x-ray (five), colonoscopy (three), endoscopic retrograde cholangiopancreatography (two), and upper gastrointestinal x-ray (two).
RESULTS: Patients with abdominal pain generally presented with right upper quadrant discomfort. Thirty-one patients (17%) had pain at study entry: 33% of these had pain persisting at 1 yr, and 20% of these had pain persisting at 2 yr. The resolution of pain was not clearly affected by ursodeoxycholic acid. Evaluation with ultrasound and upper endoscopy found four patients with asymptomatic cholelithiasis, one with esophageal erosions, four with gastric erosions, one with a gastric ulcer, and two with duodenal erosions. Additional tests were unrevealing in 14 patients. Patients with pain were similar to patients without pain with regard to age, histological stage, gender, and liver biochemistries.
CONCLUSIONS: We conclude that chronic right upper quadrant pain is not uncommon in patients with primary biliary cirrhosis, that it usually resolves spontaneously, and that upper endoscopy is the most important diagnostic test to use to exclude treatable causes of pain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7942679

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  7 in total

Review 1.  Ursodeoxycholic acid for primary biliary cirrhosis.

Authors:  Jelena S Rudic; Goran Poropat; Miodrag N Krstic; Goran Bjelakovic; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

2.  Pain and opioid use in chronic liver disease.

Authors:  Shari S Rogal; Daniel Winger; Klaus Bielefeldt; Eva Szigethy
Journal:  Dig Dis Sci       Date:  2013-03-20       Impact factor: 3.199

Review 3.  Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.

Authors:  Francesca Saffioti; Kurinchi Selvan Gurusamy; Leonardo Henry Eusebi; Emmanuel Tsochatzis; Brian R Davidson; Douglas Thorburn
Journal:  Cochrane Database Syst Rev       Date:  2017-03-28

Review 4.  The diagnosis and treatment of primary biliary cirrhosis.

Authors:  Kyung-Ah Kim; Sook-Hyang Jeong
Journal:  Korean J Hepatol       Date:  2011-09

Review 5.  Primary biliary cirrhosis.

Authors:  Teru Kumagi; E Jenny Heathcote
Journal:  Orphanet J Rare Dis       Date:  2008-01-23       Impact factor: 4.123

6.  Reverse of Acute and Chronic Morphine Tolerance by Lithocholic Acid via Down-Regulating UGT2B7.

Authors:  Zizhao Yang; Li Li; Haihong Hu; Mingcheng Xu; Jingkai Gu; Zaijie Jim Wang; Lushan Yu; Su Zeng
Journal:  Front Pharmacol       Date:  2016-11-01       Impact factor: 5.810

Review 7.  Primary biliary cirrhosis.

Authors:  Simon Hohenester; Ronald P J Oude-Elferink; Ulrich Beuers
Journal:  Semin Immunopathol       Date:  2009-07-15       Impact factor: 9.623

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.